Intellicyt
Intellicyt develops high-throughput flow cytometry screening platforms (iQue HTS) for life sciences research, serving academic and biopharmaceutical customers in antibody discovery, immuno-oncology, T-cell engineering, and cell analysis applications.
- Company typePrivate
- Founded2006
- HeadquartersAlbuquerque, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Intellicyt does
Intellicyt Corporation is a life sciences instrumentation company founded in 2006 and headquartered in Albuquerque, New Mexico, that develops and markets high-throughput cell and bead-based screening solutions built around flow cytometry. The company's core offering, the iQue HTS Platform (latest generation iQue 5 launched in 2026), combines patented sampling technology with up to 4-laser, 27-channel configurations to process 96-well plates in as little as 5 minutes and 384-well plates in 20 minutes, enabling multiplexed analysis of cell phenotype and function. The platform is supported by the proprietary iQue Forecyt software for acquisition, analysis, and real-time data visualization, complemented by validated reagent kits and design tools including the iQue Cytometry Panel Builder and the iQue Qbeads Assay Builder.
Intellicyt generates revenue through a three-stream model: one-time license sales of iQue cytometer instruments (iQue 5, iQue 3, iQue Screener Plus), recurring consumables and reagent sales (mix-and-read kits, fluorophore-conjugated antibodies, and assay-specific reagents), and professional services (installation, training, technical support, and repair). Distribution runs through enterprise field sales, the Sartorius Shop e-commerce platform with account-verified customer-specific pricing, and a global technical support organization, reflecting an integration with Sartorius's commercial infrastructure. End customers span academic research institutions, biopharmaceutical companies, and contract research organizations, with primary use cases in antibody discovery and characterization, immuno-oncology and T-cell engineering, cytokine profiling, and live-cell analysis research, validated by more than 1,300 peer-reviewed scientific references.
Intellicyt firmographics
Firmographics- Name
- Intellicyt
- Legal name
- Intellicyt
- Website
- https://intellicyt.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Intellicyt develops high-throughput flow cytometry screening platforms (iQue HTS) for life sciences research, serving academic and biopharmaceutical customers in antibody discovery, immuno-oncology, T-cell engineering, and cell analysis applications.
- Ownership category
- akta.pro rank
Intellicyt industry classification
Industry- Product category
- High-Throughput Flow Cytometry Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Intellicyt is headquartered
LocationHeadquarters
- HQ city
- Albuquerque
- HQ country
- United States
- HQ region
- North America
Markets served
Intellicyt business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- HTS Cytometry Instruments and Software: Sale of iQue® HTS cytometer instruments (iQue 5, iQue 3, iQue Screener Plus) along with proprietary iQue Forecyt® software for acquisition, analysis, and data visualization. Instruments process 96 or 384-well plates and can connect to automation systems for continuous plate loading.
- Consumables and Reagents: Recurring revenue from proprietary iQue® reagent kits validated for use on the iQue HTS Platform. Includes optimized mix-and-read reagent kits, fluorophore-conjugated antibodies, and assay-specific reagents.
- Technical Support and Services: Global Technical Support team provides expert installation, training, technical support and repair services to customers worldwide.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise instrument pricing — custom quotes for iQue HTS cytometer platforms |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Intellicyt product offering
Product offeringCore offering
Intellicyt develops and markets high-throughput cell and bead-based screening solutions built around the iQue HTS Platform. The offering combines flow cytometry instruments (iQue 5, iQue 3, iQue Screener Plus) with the iQue Forecyt acquisition and analysis software, validated mix-and-read reagent kits, and supporting assay design tools such as the iQue Cytometry Panel Builder and iQue Qbeads Assay Builder. The platform enables live-cell, multiplexed analysis of cell phenotype and function for antibody discovery, T-cell engineering, and immuno-oncology research workflows.
Product overview
The iQue High-Throughput Screening (HTS) Platform by Sartorius is a comprehensive cytometry solution comprising multiple integrated components. The core offering includes the iQue 5 Platform (latest generation instrument with 96/384-well plate processing), the iQue Forecyt Software for acquisition and analysis, and iQue HTS Cytometry Reagents (validated kits). Supporting tools include the iQue Cytometry Panel Builder for panel design and the iQue Qbeads Assay Builder for multiplex assay creation. Previous generation products (iQue 3 and iQue Screener Plus) serve established workflows. The platform enables live-cell, multiplexed analysis of cell phenotype and function supporting applications in antibody discovery, T-cell engineering, and immuno-oncology research.
Differentiator
Problem solved
Functional benefit
Products and services
- iQue 5 High-Throughput Screening (HTS) Platform Advanced high-throughput flow cytometry instrument capable of processing 96-well plates in 5 minutes and 384-well plates in 20 minutes, with up to 4 laser excitation and 27 channel configurations for multiplexed cell analysis. Targets antibody discovery, T-cell engineering, and immuno-oncology research workflows at biopharmaceutical and academic research institutions.
- iQue Forecyt Software Integrated acquisition and analysis software enabling interactive assay development, analysis and multiparameter data visualization with real-time plate-wide updates when gates are adjusted. Used by researchers running multiplexed cell screening workflows on iQue HTS instruments.
- iQue HTS Cytometry Reagents Validated mix-and-read reagent kits optimized for use on the iQue HTS Platform with ready-to-use analysis templates. Supports antibody characterization, cytokine profiling, and cell health analysis applications for biopharmaceutical and academic research customers.
- iQue Cytometry Panel Builder Intelligent web-based tool that helps researchers design optimal multi-color flow cytometry panels tailored to their specific experimental needs. Used by researchers planning multiplexed assays on the iQue HTS Platform.
- iQue Qbeads Assay Builder Easy-to-use web-based tool for designing custom multiplex bead-based assays using iQue Qbeads technology. Supports biomarker analysis applications across antibody discovery and life science research workflows.
- iQue 3 High-Throughput Screening Platform Previous generation high-throughput screening cytometer platform with established workflow capabilities for flow cytometry-based screening applications. Sold to biopharmaceutical and academic research customers running established screening workflows.
- iQue Screener Plus Previous generation screening cytometer variant offering high-throughput flow cytometry analysis capabilities for various screening applications across antibody discovery and life science research workflows.
Quantifiable outcome
- 96 wells processed in as little as 5 minutes; 384 wells in 20 minutes
- +2 more outcomes
Companies that use Intellicyt
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Intellicyt technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Intellicyt partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- University of CopenhagencoreAcademic partnership where University of Copenhagen immunology researchers use the iQue HTS Platform for advanced high throughput cytometry to direct drug selection in patients with relapsed Acute Myeloid Leukemia. This collaboration demonstrates the platform's application in translational cancer research.
- University of LiverpoolcoreAcademic partnership where researchers use HTS cytometry to detect uptake and transport across membranes of small molecules by microbes for small molecule discovery applications. Demonstrates platform utility in microbiology and drug discovery research.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
Intellicyt competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific (Attune NxT): Thermo Fisher's Attune NxT acoustic-focused flow cytometer and broader life sciences portfolio compete head-to-head with the iQue HTS platform in research cytometry applications across pharma and academic labs.
- BD Biosciences: BD Biosciences (a segment of Becton Dickinson) is the dominant incumbent in flow cytometry, offering instruments such as FACSChorus, FACSDiscover, and BD Accuri that directly compete with the iQue HTS platform for cell analysis workflows in antibody discovery and immuno-oncology research.
- Beckman Coulter Life Sciences: Beckman Coulter's CytoFLEX and Biomek lines compete with the iQue in high-throughput flow cytometry and screening workflows for academic and biopharma customers, with overlapping capabilities in multiplexed cell analysis.
Direct peers
- Cytek Biosciences: Cytek's Northern Lights spectral flow cytometry platform and Aurora systems are direct flow cytometry peers to the iQue platform, targeting similar high-content, multiplexed cell analysis use cases in immuno-oncology and cell therapy research.
- Bio-Rad Laboratories (ZE5 Cell Analyzer): Bio-Rad's ZE5 and S3e flow cytometry instruments and StarBright reagents compete with the iQue HTS platform for high-throughput, multi-user cell analysis in academic and biopharma research environments.
- Agilent (ACEA Biosciences): Agilent's ACEA Biosciences xCELLigence and NovoCyte flow cytometry platforms compete in real-time cell analysis and high-throughput screening, overlapping with iQue's immuno-oncology and cell function analysis applications.
Others
- Sartorius AG: Sartorius AG is Intellicyt's parent/acquirer and operates the High-Throughput Cytometry product line covering the iQue platform. Although not a peer in a competitive sense, it is the relevant corporate vehicle through which Intellicyt's technology is currently distributed.
Emerging players
- Eurofins DiscoverX: Eurofins DiscoverX provides bead-based and cell-based assay kits and instrumentation services that overlap with iQue's reagent kits and Qbeads multiplex assay workflow for drug discovery screening applications.
- Curiox Biosystems: Curiox provides miniaturized washing and sample preparation automation for bead-based and cell-based assays, complementing and partly competing with the automation integration value proposition of the iQue HTS platform.
- Cytovation (CellRaft AIR): Cytovation's CellRaft technology and AIR system is an emerging single-cell sorting and analysis platform targeting similar antibody discovery and cell engineering use cases where the iQue Qbeads and Forecyt software operate.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks4 records
Key highlights5 records
Customer concentration
Intellicyt social profiles
Digital presenceIntellicyt financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intellicyt leadership team
Management profileNumber of profiles
Profiles1 record
Intellicyt funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intellicyt M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intellicyt
What does Intellicyt do?
Intellicyt develops and markets high-throughput cell and bead-based screening solutions built around the iQue HTS Platform. The offering combines flow cytometry instruments (iQue 5, iQue 3, iQue Screener Plus) with the iQue Forecyt acquisition and analysis software, validated mix-and-read reagent kits, and supporting assay design tools such as the iQue Cytometry Panel Builder and iQue Qbeads Assay Builder. The platform enables live-cell, multiplexed analysis of cell phenotype and function for antibody discovery, T-cell engineering, and immuno-oncology research workflows.
Is Intellicyt a public or private company?
Intellicyt is a private company. It is classified as corporate owned and is currently operating.
When was Intellicyt founded?
Intellicyt was founded in 2006. It employs 11 to 50 people.
Where is Intellicyt based?
Intellicyt is headquartered in Albuquerque, United States, in the North America region.
How does Intellicyt make money?
Three revenue lines are on record. HTS Cytometry Instruments and Software is the primary driver. The others are consumables and Reagents and technical Support and Services.
Who are Intellicyt's main competitors?
Broad incumbents on record are Thermo Fisher Scientific (Attune NxT), BD Biosciences and Beckman Coulter Life Sciences. Direct peers are Cytek Biosciences, Bio-Rad Laboratories (ZE5 Cell Analyzer) and Agilent (ACEA Biosciences). Sartorius AG is listed as an others. Emerging players are Eurofins DiscoverX, Curiox Biosystems and Cytovation (CellRaft AIR).
Does Intellicyt have an API?
No public API is recorded for Intellicyt.
What industry is Intellicyt in?
Intellicyt's product category is High-Throughput Flow Cytometry Instruments. Its primary akta.pro industry code is HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 334516 and its SIC code is 3826.